OraVerse® in Practice
A solution that's easy to incorporate
In a time when many new dental technologies require training, equipment and setup time, OraVerse is a solution that fits simply with the way you practice today.
OraVerse is easy to use
- Easy administration
- Same injection site
- Same technique as the local anesthetic
- Dosing
- 1:1 cartridge ratio to local anesthetic
- Maximum recommended dose
- 2 cartridges for adults and adolescents 12 and older
- 1 cartridge for patients 6-11 years of age and over 66 lbs.
- 1/2 cartridge for children 6-11 years of age and weighing 33-66 lbs.
- Ideal for common restorative and periodontal maintenance procedures
- Cavity preparations
- Crown preparations and placement
- Inlays, onlays and veneers
- Non-surgical periodontal scaling and root planing
OraVerse is indicated for use in adults and children 6 years of age or older and weighing at least 33 lbs.
The most common adverse events with OraVerse that were greater than the control group were injection site pain (5% vs. 4%) and bradycardia (2% vs. 0.3%).
Important Safety Information
Following parenteral use of phentolamine at doses between 5 and 15 times higher than the recommended dose of OraVerse (phentolamine mesylate), myocardial infarction and cerebrovascular spasm and occlusion have been reported, usually in association with marked hypotensive episodes producing shock-like states. Although such effects are uncommon with OraVerse, clinicians should be alert to the signs and symptoms of tachycardia, bradycardia, and cardiac arrhythmias, particularly in patients with a history of cardiovascular disease, as these symptoms may occur with the use of phentolamine or other alpha-adrenergic blocking agents. See full prescribing information for details.
